FDA, Generic Manufacturers Want Faster GDUFA Approvals

Monday, June 22, 2015


Generics industry groups told FDA officials during a public meeting Monday that review times and approvals of generic drugs have slipped significantly since implementation of the Generic Drug User Fee Act, and they called for major changes when the program is reauthorized in fiscal 2018.

View All News »